Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2006 | 1 |
2007 | 2 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.
J Infect Dis. 2006 Sep 1;194(5):584-7. doi: 10.1086/505912. Epub 2006 Jul 25.
J Infect Dis. 2006.
PMID: 16897655
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
Haque T, Wilkie GM, Taylor C, Amlot PL, Murad P, Iley A, Dombagoda D, Britton KM, Swerdlow AJ, Crawford DH.
Haque T, et al. Among authors: dombagoda d.
Lancet. 2002 Aug 10;360(9331):436-42. doi: 10.1016/S0140-6736(02)09672-1.
Lancet. 2002.
PMID: 12241714
Clinical Trial.
Item in Clipboard
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Rosenblatt J, Vasir B, Uhl L, Blotta S, Macnamara C, Somaiya P, Wu Z, Joyce R, Levine JD, Dombagoda D, Yuan YE, Francoeur K, Fitzgerald D, Richardson P, Weller E, Anderson K, Kufe D, Munshi N, Avigan D.
Rosenblatt J, et al. Among authors: dombagoda d.
Blood. 2011 Jan 13;117(2):393-402. doi: 10.1182/blood-2010-04-277137. Epub 2010 Oct 28.
Blood. 2011.
PMID: 21030562
Free PMC article.
Clinical Trial.
Item in Clipboard
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, Patterson LJ, Korioth-Schmitz B, Buzby A, Dombagoda D, Montefiori DC, Letvin NL, Cafaro A, Ensoli B, Robert-Guroff M.
Demberg T, et al. Among authors: dombagoda d.
J Virol. 2007 Apr;81(7):3414-27. doi: 10.1128/JVI.02453-06. Epub 2007 Jan 17.
J Virol. 2007.
PMID: 17229693
Free PMC article.
Item in Clipboard
No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys.
Letvin NL, Rao SS, Dang V, Buzby AP, Korioth-Schmitz B, Dombagoda D, Parvani JG, Clarke RH, Bar L, Carlson KR, Kozlowski PA, Hirsch VM, Mascola JR, Nabel GJ.
Letvin NL, et al. Among authors: dombagoda d.
J Virol. 2007 Nov;81(22):12368-74. doi: 10.1128/JVI.00822-07. Epub 2007 Aug 8.
J Virol. 2007.
PMID: 17686853
Free PMC article.
Item in Clipboard
Cite
Cite